NCT00768443
Completed
N/A
Epidemiological Study to Assess the Symptom Patterns and Management Strategies in Patients Consulting With Persistent GERD Symptoms in Primary Care
ConditionsGastroesophageal Reflux Disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Gastroesophageal Reflux Disease
- Sponsor
- AstraZeneca
- Enrollment
- 2674
- Locations
- 1
- Primary Endpoint
- To assess the symptom load and impact on daily life in PPI-treated GERD patients with persistent GERD symptoms
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
This a non-interventional multi-centre study to evaluate the symptom load and management strategies in PPI-treated GERD patients with persistent GERD symptoms..
Investigators
Eligibility Criteria
Inclusion Criteria
- •Provision of informed consent
- •Subjects with a diagnosis of GERD and with predominant typical GERD symptoms: heartburn/regurgitation
- •Subjects who fail to obtain satisfactory symptomatic response after their first full course (4-8 weeks) of standard dose PPI (once a day)
Exclusion Criteria
- •Inability to read and/or understand Patient Reported Outcomes questionnaires
- •Subjects where the only reason for the visit is renewing the prescription
- •A history of an incomplete response to PPI treatment prior to current course of treatment
Outcomes
Primary Outcomes
To assess the symptom load and impact on daily life in PPI-treated GERD patients with persistent GERD symptoms
Time Frame: Once, at first visit
Secondary Outcomes
- To describe the frequency and severity of extra-oesophageal and/or atypical GERD symptoms and to assess the concordance between patient-reported and physician-reported symptom load(Once, at first visit)
- To describe current and previous treatment strategies and to describe the diagnostic and therapeutic approaches during the study visit(Once, at first visit)
- To describe the impact of persistent GERD symptoms on work productivity(Once, at first visit)
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in CanadaIdiopathic Pulmonary FibrosisNCT02552849Hoffmann-La Roche305
Active, Not Recruiting
N/A
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With AlectinibNSCLCNCT04764188Hoffmann-La Roche800
Completed
N/A
Study to Assess Iron Chelation Therapy in Patients With Chronic Iron OverloadChronic Iron OverloadNCT05440487Novartis Pharmaceuticals489
Completed
N/A
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsDiabetesNCT02208921AstraZeneca3,000
Completed
N/A
Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary HyperparathyroidismPrimary HyperparathyroidismNCT01776502Nantes University Hospital116